Incidence and predictors of flares after discontinuing nucleos (t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP study

被引：0
|
作者：
Liem, Seng [1 ,2 ]
Fung, Scott [1 ]
Wong, David [1 ]
Yim, Colina [1 ]
Chen, Jenny [1 ]
Noureldin, Seham [1 ]
Feld, Jordan [1 ,3 ]
Hansen, Bettina [1 ,2 ,4 ]
Janssen, Harry [1 ]
机构：
[1] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada
[2] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[3] McLaughlin Rotman Ctr Global Hlth, Toronto, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30935-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-190
引用
收藏
页码：E474 / E474
页数：1
相关论文
共 50 条
  • [1] Hepatic flares after nucleos (t)ide analogue cessation in HBeAg-negative hepatitis B: results from the Nuc-Stop study
    Holmberg, Marte
    Dalgard, Olav
    Aleman, Soo
    Berhe, Nega
    Dessalegn, Hailemichael
    Weis, Nina
    Heggelund, Lars
    Karlsen, Lars Normann
    Brugger-Synnes, Pascal
    Simonsen, Hans Erling
    Reikvam, Dag Henrik
    Johannessen, Asgeir
    JOURNAL OF HEPATOLOGY, 2024, 80 : S795 - S795
  • [2] Serum HBV RNA levels after nucleos(t)ide analogue therapy withdrawal in HBeAg negative patients with chronic hepatitis B: results from the Toronto STOP Study
    Liem, Kin Seng
    van Boemmel, Florian
    Farag, Mina S.
    Fung, Scott K.
    Wong, David K. H.
    Yim, Colina K.
    Chen, Jiayun
    Rother, Karen
    Berg, Thomas
    Feld, Jordan J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2019, 70 : 614A - 614A
  • [3] Stopping Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B
    Liaw, Yun-Fan
    GASTROENTEROLOGY, 2020, 159 (03) : 1186 - 1186
  • [4] Stopping Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B Reply
    Liem, K. Seng
    Gehring, Adam J.
    Janssen, Harry L. A.
    GASTROENTEROLOGY, 2020, 159 (03) : 1187 - 1188
  • [5] A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B
    van Boemmel, Florian
    Stein, Kerstin
    Heyne, Renate
    Petersen, Joerg
    Buggisch, Peter
    Berg, Christoph
    Zeuzem, Stefan
    Stallmach, Andreas
    Sprinzl, Martin
    Schott, Eckart
    Pathil-Warth, Anita
    von Arnim, Ulrike
    Keitel, Verena
    Lohmeyer, Juergen
    Simon, Karl-Georg
    Trautwein, Christian
    Trein, Andreas
    Hueppe, Dietrich
    Cornberg, Markus
    Lammert, Frank
    Ingiliz, Patrick
    Zachoval, Reinhart
    Hinrichsen, Holger
    Zipprich, Alexander
    Klinker, Hartmuth
    zur Wiesch, Julian Schulze
    Schmiedeknecht, Anett
    Brosteanu, Oana
    Berg, Thomas
    JOURNAL OF HEPATOLOGY, 2023, 78 (05) : 926 - 936
  • [6] Durability after discontinuation of nucleos(t) ide therapy in chronic HBeAg negative hepatitis patients
    Kim, Young Jip
    Kim, Kichan
    Hwang, Sun Hyuk
    Kim, Soon Sun
    Lee, Dami
    Cheong, Jae Youn
    Cho, Sung Won
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (03) : 300 - 304
  • [7] Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B: To Retreat or Not to Retreat
    Liaw, Yun-Fan
    HEPATOLOGY, 2021, 73 (02) : 843 - 852
  • [8] A comment on "A multicenter randomized-controlled trial of nucleos(t)ide analogue cessation in HBeAg-negative chronic hepatitis B"
    Wan, Yue-Meng
    Wu, Hua -Mei
    Huang, Song-Quan
    Li, Hua -Yu
    Yin, Hong -Jing
    JOURNAL OF HEPATOLOGY, 2024, 80 (05) : e229 - e230
  • [9] The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B
    Wong, Grace L. -H.
    Chan, Henry L. -Y.
    Yuen, Becky W. -Y.
    Tse, Yee-Kit
    Luk, Hester W. -S.
    Yip, Terry C. -F.
    Hui, Vicki W. -K.
    Liang, Lilian Y.
    Lee, Hye-Won
    Lui, Grace C. -Y.
    Wong, Vincent W. -S.
    LIVER INTERNATIONAL, 2020, 40 (03) : 549 - 557
  • [10] Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B
    Kranidioti, Hariklia
    Manolakopoulos, Spilios
    Kontos, George
    Breen, Michael S.
    Kourikou, Anastasia
    Deutsch, Melanie
    Quesada-Del-Bosque, Maria Ester
    Martinez-Nunez, Rocio T.
    Naiyer, Mohammed M.
    Woelk, Christopher H.
    Sanchez-Elsner, Tilman
    Hadziyannis, Emilia
    Papatheodoridis, George
    Khakoo, Salim, I
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (06) : 697 - 709
12345